KRAS and colorectal carcinoma: Similar to strategies to suppress KRAS signaling pathway and function, developing attempts at direct targeting KRAS is anticipated to be long and difficult way.10 As mentioned above, there are no effective therapies for KRAS‐mutated CRC, and furthermore, the exact molecular pathology of CRC with KRAS mutations is still unsolved.